when is the best time to take glp-1 drops Can You a Drug Less Often if You're at Your Goal Weight? When to Titrate Up Your

This approach is inspired by the expert consensus statement by Sievenpiper and colleagues (2026) on nutritional management for individuals treated with GLP-1 receptor agonists

Discussion In our practice, GLP-1 RA initiation is considered as a potential adjunct therapy in overweight and obese people with type 1 diabetes

Yao PY, Alvarado AC, Schaefer TJ

Peptide therapy is not recommended for individuals who are: -Pregnant or breastfeeding -Diagnosed with active cancer or hormone-sensitive tumors or high risk -Undergoing immunosuppressive therapy (unless cleared by their specialist) -Experiencing uncontrolled endocrine disorders Always consult your provider and disclose your full medical history before starting any peptide protocol

Wegovy has an FDA-approved indication to reduce the risk of major adverse cardiovascular events, including cardiovascular death, nonfatal heart attack, and nonfatal stroke, in adults with established cardiovascular disease and either obesity or overweight